We are live on ! Find out more
Cambridge Investment Research Advisors

Cambridge Investment Research Advisors Portfolio holdings

AUM $44.6B
1-Year Est. Return 28.94%
This Fund
S&P 500
This Quarter Est. Return
-1.29%
1 Year Est. Return
+28.94%
3 Year Est. Return
+82.62%
5 Year Est. Return
+90.41%
10 Year Est. Return
+293.66%
AUM
$3.39B
AUM Growth
+$526M
Cap. Flow
+$586M
Cap. Flow %
17.28%
Top 10 Hldgs %
16.92%
Holding
1,543
New
205
Increased
822
Reduced
368
Closed
82
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
GTAT
1376
DELISTED
GT ADVANCED TECHNOLOGIES INC COM STK (DE)
GTAT
$125K ﹤0.01%
11,575
+1,350
+13% +$20.6K
JCP
1377
DELISTED
J.C. Penney Company, Inc.
JCP
$124K ﹤0.01%
12,395
-2,747
-18% -$26.9K
STM icon
1378
STMicroelectronics
STM
$49.1B
$123K ﹤0.01%
+16,053
New +$134K
ABEV icon
1379
Ambev
ABEV
$43.9B
$119K ﹤0.01%
+18,203
New +$128K
PDEX icon
1380
Pro-Dex
PDEX
$213M
$118K ﹤0.01%
51,850
MBI icon
1381
MBIA
MBI
$253M
$117K ﹤0.01%
+12,750
New +$125K
MHY
1382
DELISTED
WESTERN ASSET MANAGED HIGH INCOM FD INC. COM
MHY
$116K ﹤0.01%
20,992
+4,441
+27% +$25K
KMM
1383
DELISTED
Deutsche Multi-Market Incm Trust
KMM
$114K ﹤0.01%
12,919
+25
+0.2% +$230
EVBS
1384
DELISTED
Eastern Virginia Bankshares In
EVBS
$114K ﹤0.01%
18,338
OWW
1385
DELISTED
ORBITZ WORLDWIDE, INC
OWW
$113K ﹤0.01%
+14,360
New +$123K
SCLN
1386
DELISTED
Sciclone Pharmaceuticals Inc
SCLN
$112K ﹤0.01%
16,275
+100
+0.6% +$599
VVR icon
1387
Invesco Senior Income Trust
VVR
$460M
$111K ﹤0.01%
23,438
-1,485
-6% -$7.22K
JBLU icon
1388
JetBlue
JBLU
$2.19B
$110K ﹤0.01%
+10,369
New +$118K
OIA icon
1389
Invesco Municipal Income Opportunities Trust
OIA
$290M
$108K ﹤0.01%
15,905
+2,140
+16% +$14.7K
ALU
1390
DELISTED
Alcatel-Lucent
ALU
$106K ﹤0.01%
34,990
-41
-0.1% -$140
SRL icon
1391
Scully Royalty
SRL
$89.8M
$105K ﹤0.01%
2,949
TRX icon
1392
TRX Gold Corp
TRX
$350M
$103K ﹤0.01%
49,050
-3,000
-6% -$6.83K
RTK
1393
DELISTED
Rentech, Inc.
RTK
$97K ﹤0.01%
5,663
-438
-7% -$9.52K
HYF
1394
DELISTED
MANAGED HIGH YLD PLUS FD INC
HYF
$97K ﹤0.01%
48,684
DHY
1395
Credit Suisse High Yield Credit Fund
DHY
$242M
$96K ﹤0.01%
31,037
OPCH icon
1396
Option Care Health
OPCH
$3.61B
$93K ﹤0.01%
3,375
RJI
1397
DELISTED
AB Svensk Ekportkredit ELEMENTS Linked to the Rogers International Commodity Index-Total Return
RJI
$93K ﹤0.01%
12,400
-5,179
-29% -$41.7K
AUQ
1398
DELISTED
AURICO GOLD INC COM
AUQ
$92K ﹤0.01%
26,225
+1,940
+8% +$7.99K
DSU icon
1399
BlackRock Debt Strategies Fund
DSU
$600M
$91K ﹤0.01%
7,934
+97
+1% +$1.15K
SVM
1400
Silvercorp Metals
SVM
$2.79B
$90K ﹤0.01%
56,832
+2,502
+5% +$4.6K

Similar funds

Cambridge Investment Research Advisors's Q3 2014 Portfolio in Review

As of Q3 2014, Cambridge Investment Research Advisors held 1,543 positions worth $3.39B, up 18% from $2.87B the previous quarter. Its ten largest holdings account for 17% of the portfolio.

Cambridge Investment Research Advisors deployed $586M of net new capital in Q3 2014, opening 205 new positions and adding to 822 existing holdings. Its largest new stake was Vanguard S&P 500 ETF: 556,997 shares worth $101M.

By sector, the portfolio is most concentrated in Energy at 5.4% of assets, down from 6.5% a quarter earlier, followed by Financials and Technology.

On the sell side, the largest reduction was iShares Russell 3000 ETF, an estimated $20M trimmed.

  • Cambridge Investment Research Advisors's largest Q3 2014 buy was Vanguard S&P 500 ETF: 556,997 shares worth $101M.
  • Cambridge Investment Research Advisors added most to Barclays Bank Plc in Q3 2014, an estimated $45.8M increase.
  • Cambridge Investment Research Advisors's biggest Q3 2014 reduction was iShares Russell 3000 ETF, cutting an estimated $20M.
  • Cambridge Investment Research Advisors fully exited iShares MSCI Taiwan ETF in Q3 2014, selling an estimated $1.83M.
  • Cambridge Investment Research Advisors's ten largest holdings make up 17% of its $3.39B portfolio in Q3 2014.
  • Cambridge Investment Research Advisors opened 205 new positions and closed 82 in Q3 2014.
  • Cambridge Investment Research Advisors's portfolio value rose 18% quarter-over-quarter to $3.39B.

Based on Cambridge Investment Research Advisors's 13F filing for Q3 2014, filed 5 Nov 2014.